SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 76 filers reported holding SILVERBACK THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $534,000 | -50.2% | 151,608 | -5.9% | 0.00% | 0.0% |
| Q4 2021 | $1,073,000 | -31.1% | 161,173 | +3.2% | 0.00% | -50.0% |
| Q3 2021 | $1,558,000 | -69.2% | 156,136 | -4.7% | 0.00% | -66.7% |
| Q2 2021 | $5,058,000 | +10.9% | 163,755 | +56.7% | 0.01% | 0.0% |
| Q1 2021 | $4,559,000 | -57.6% | 104,497 | -55.0% | 0.01% | -25.0% |
| Q4 2020 | $10,754,000 | – | 232,074 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 8,740,887 | $87,234,000 | 0.96% |
| Boxer Capital, LLC | 1,675,377 | $16,720,000 | 0.58% |
| EcoR1 Capital, LLC | 1,184,710 | $11,823,000 | 0.41% |
| Nantahala Capital Management | 1,226,631 | $12,242,000 | 0.39% |
| 5AM Venture Management, LLC | 169,748 | $1,694,000 | 0.34% |
| COMMODORE CAPITAL LP | 97,143 | $969,000 | 0.26% |
| RA Capital Management | 1,742,186 | $17,387,000 | 0.24% |
| HighVista Strategies LLC | 22,434 | $224,000 | 0.15% |
| Rhenman & Partners Asset Management AB | 150,000 | $1,497,000 | 0.10% |
| Woodline Partners LP | 425,261 | $4,244,000 | 0.07% |